“…Taking into account the sensitivity and specificity of the test used (Hartmann and others 2007), the estimated true prevalence for FIV was 19.3%; however with wide 95% CI (14.7% to 24.0%), which reduces slightly the reliability of this estimation. This FIV seroprevalence is much higher than most of those previously reported from European countries, including northern Belgium, whatever the lifestyle or health status of the population studied (Hosie and others 1989, Lutz and others 1990, Hartmann and Hinze 1991, Arjona and others 1992, Bandecchi and others 1992, Ueland and Lutz 1992, Fuchs and others 1994, Peri and others 1994, Sukura and others 1992, Holznagel and others 1997, Knotek and others 1999, Dorny and others 2002, Muirden 2002, Bandecchi and others 2006, Gleich and others 2009, Murray and others 2009, Duarte and others 2012, Spada and others 2012, Rypuła and others 2014). In addition, the mean FIV seroprevalence over three years in the present study is likely an underestimation of the actual prevalence, since FIV‐positive cats were systematically removed from the population since 2010, which introduced a bias in the estimation of crude FIV seroprevalence during the years 2011 and 2012.…”